Experience sharing is critical for women in science Sharing experiences with future generations is key to moving science and biotechnology forward. As a female leader of a biotechnology company, Dr. Bridget Martell, CEO of Artizan Biosciences, shares her experiences and perspectives with ScienceBoard.Read More
Focus on drug-manufacturing optimization prioritizes patient health As medical innovations and therapeutics advance rapidly and dramatically increase in scale, there is a critical need for manufacturing processes that can keep up with this pace. This often calls for updates, overhauls, and collaboration among companies to maintain such a high standard of production.Read More
Giving a voice to professionals of color is important in the life sciences Creating an environment where professionals of color feel empowered to use their voice and confidence that they will be heard is critical to business success, according to Pratt Wiley, CEO of The Partnership. He spoke with ScienceBoard about some of the important work the organization is leading to support diversity, equity, and inclusion in the workplace.Read More
Scientists improve ADC development with mix of experimental, computational tools BOSTON -- Greg Thurber, PhD, professor at the University of Michigan explained how his lab is jointly using both experimental animal models and computational models to improve the overall speed and efficiency of drug development of antibody-drug conjugates (ADCs) to get more of the agents on the market. Thurber presented in a scientific session at the Society for Laboratory Automation and Screening (SLAS) 2022 International Conference and Expo.Read More
Step toward broader treatment for Duchenne muscular dystrophy Current therapies to treat Duchenne muscular dystrophy, a genetic muscle-wasting disease, only work in a small proportion of people with the condition. Research published on February 21 in the Proceedings of the National Academy of Science provides a proof of concept for developing a therapy that could work for almost half of the people affected.Read More
How one company is helping make complex medicines safer Often, the most dangerous things in life are things that the human eye cannot see. This is true even for life-saving medicines. One company was founded to help the industry find these hidden particles and solve a key challenge in the development of complex drug products. Halo Labs’ CEO Rick Gordon spoke with ScienceBoard about how its low volume approach is providing a critical service for the drug development industry.Read More
Federal R&D funding for universities tops 3% in fiscal year 2021 Federally funded R&D for U.S. higher education universities grew 3.3% to $86.4 billion in fiscal year 2021 (end-September 30, 2021), according to the latest statistics from the National Science Foundation. Funding from the federal government accounted for 53% of the total and increased 3.7%.Read More
Applied DNA and EvviVax publish data for potential cancer immunotherapy Applied DNA Sciences and EvviVax have published a manuscript detailing a preclinical study showing that LinearDNA vaccines used for cancer immunotherapy produced a strong immune and specific antitumoral response in preclinical mouse models. The study investigated the use of the LinearDNA platform to produce DNA vaccines targeting either tumor-associated antigens (TAAs) or tumor-specific antigens (TSAs, or tumor neoantigens).Read More
Machine vision advances single-cell sequencing for small samples The ability to sequence RNA in single cells has given scientists an unprecedented level of resolution in studying rare cell types. However, current approaches are designed to deal with a large number of cells, making it difficult to work with small samples. New research, published in Nature Methods on February 14, has described a technique using machine vision to detect cells and make single-cell RNA sequencing more efficient at a smaller scale.Read More